Trade Summary

2 days ago, Peetz Christopher, serving as CEO at Mirum Pharmaceuticals, Inc. (MIRM), sold 40,985 shares at $91.98 per share, for a total transaction value of $3,769,714.00. Following this transaction, Peetz Christopher now holds 381,809 shares of MIRM.

This sale represents a 10.00% decrease in Peetz Christopher's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 1 day after the trade was made.

Mirum Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.